Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Select Drug Profiles
FDA Approvals
Ofatumumab Approved for Patients with CLL
Read More
FDA Approvals
Ibrutinib Approved for CLL
Read More
FDA Approvals
First Drug Combination Approved for Unresectable or Metastatic Melanoma
Read More
Site of Service Influences Value
Caroline Helwick
Read More
Value-Based Insurance Not Such an Easy Sell
Caroline Helwick
Read More
What Makes a Treatment Clinically Meaningful?
Caroline Helwick
Read More
ASCO Beginning to Address Value in Oncology
Caroline Helwick
Read More
Lung Cancer
,
Oncology
Ramucirumab Shows Survival Benefit in NSCLC
Caroline Helwick
Read More
Federal Spending on Cancer Research and Access to Care Woefully Inadequate
Wayne Kuznar
Read More
FDA Approvals
Anti–PD-1 Antibodies for NSCLC and Renal Carcinoma
Caroline Helwick
Read More
144
145
146
147
148
149
150
Page 147 of 244
Results 1461 - 1470 of 2438
